TR199902138A2 - Trovafloksasin asit tuzlar�n�n haz�rlanmas�. - Google Patents

Trovafloksasin asit tuzlar�n�n haz�rlanmas�.

Info

Publication number
TR199902138A2
TR199902138A2 TR1999/02138A TR9902138A TR199902138A2 TR 199902138 A2 TR199902138 A2 TR 199902138A2 TR 1999/02138 A TR1999/02138 A TR 1999/02138A TR 9902138 A TR9902138 A TR 9902138A TR 199902138 A2 TR199902138 A2 TR 199902138A2
Authority
TR
Turkey
Prior art keywords
acid
trovafloxacin
acid salts
preparation
trovafloxacin acid
Prior art date
Application number
TR1999/02138A
Other languages
English (en)
Turkish (tr)
Inventor
Norris Timothy
Robert Rose Peter
Michael Devries Keith
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of TR199902138A2 publication Critical patent/TR199902138A2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
TR1999/02138A 1998-09-03 1999-09-02 Trovafloksasin asit tuzlar�n�n haz�rlanmas�. TR199902138A2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9894498P 1998-09-03 1998-09-03

Publications (1)

Publication Number Publication Date
TR199902138A2 true TR199902138A2 (xx) 2000-04-21

Family

ID=22271674

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02138A TR199902138A2 (xx) 1998-09-03 1999-09-02 Trovafloksasin asit tuzlar�n�n haz�rlanmas�.

Country Status (40)

Country Link
US (1) US6359137B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0989119A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP3354526B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR20000022858A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1248580A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AP (1) AP1118A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR021475A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU761035B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG103703A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR9904082A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2281244C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CO (1) CO5251466A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EA (1) EA002340B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EE (1) EE04118B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GE (1) GEP20022785B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GT (1) GT199900142A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HN (1) HN1999000141A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HR (1) HRP990274A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUP9902967A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ID (1) ID23718A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL131614A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN191583B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IS (1) IS5168A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MA (1) MA24966A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY130800A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO994261L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ337605A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA11152A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PA (1) PA8481001A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PE (1) PE20001026A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL335246A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG74748A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK116599A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SV (1) SV1999000144A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TN (1) TNSN99164A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TR (1) TR199902138A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW520369B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UY (1) UY25686A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU43199A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA995630B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104892507B (zh) * 2015-05-26 2018-08-28 徐州天意动物药业股份有限公司 水溶性甲磺酸沙拉沙星及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
AU694149B2 (en) * 1994-01-18 1998-07-16 Pfizer Inc. Process and intermediates for preparing naphthyridonecarboxylic acid salts
WO1996039406A1 (en) * 1995-06-06 1996-12-12 Pfizer Inc. NOVEL CRYSTAL FORM OF ANHYDROUS 7-([1α, 5α, 6α]-6-AMINO-3-AZABICYCLO[3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT
JPH0912546A (ja) * 1995-06-23 1997-01-14 Chisso Corp アザビシクロ環化合物および製造方法
JPH0912547A (ja) * 1995-06-23 1997-01-14 Chisso Corp ニューキノロン系化合物中間体の製造方法
CN1190889A (zh) * 1995-08-29 1998-08-19 美国辉瑞有限公司 曲氟沙星的两性离子形式
US6184380B1 (en) * 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8464701A1 (es) * 1998-01-16 2000-09-29 Pfizer Prod Inc Procedimiento e intermedios para preparar naftiridonas

Also Published As

Publication number Publication date
UY25686A1 (es) 2000-03-31
TW520369B (en) 2003-02-11
EE04118B1 (et) 2003-08-15
BR9904082A (pt) 2000-09-12
IS5168A (is) 2000-03-04
CA2281244A1 (en) 2000-03-03
HUP9902967A2 (hu) 2000-05-28
HU9902967D0 (en) 1999-10-28
SG74748A1 (en) 2000-08-22
HUP9902967A3 (en) 2000-11-28
EA002340B1 (ru) 2002-04-25
IN191583B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2003-12-06
HRP990274A2 (en) 2000-10-31
JP2000086658A (ja) 2000-03-28
GT199900142A (es) 2001-02-15
BG103703A (bg) 2001-08-31
SK116599A3 (en) 2000-05-16
MA24966A1 (fr) 2000-04-01
EA199900708A2 (ru) 2000-04-24
NO994261D0 (no) 1999-09-02
AP9901667A0 (en) 1999-12-31
AR021475A1 (es) 2002-07-24
CA2281244C (en) 2003-05-20
PA8481001A1 (es) 2000-09-29
GEP20022785B (en) 2002-09-25
TNSN99164A1 (fr) 2005-11-10
US6359137B1 (en) 2002-03-19
CN1248580A (zh) 2000-03-29
YU43199A (sh) 2002-11-15
NZ337605A (en) 2001-03-30
EP0989119A1 (en) 2000-03-29
HN1999000141A (es) 2000-06-19
CO5251466A1 (es) 2003-02-28
EA199900708A3 (ru) 2000-08-28
ZA995630B (en) 2001-03-01
NO994261L (no) 2000-03-06
ID23718A (id) 2000-05-11
PL335246A1 (en) 2000-03-13
IL131614A0 (en) 2001-01-28
MY130800A (en) 2007-07-31
JP3354526B2 (ja) 2002-12-09
SV1999000144A (es) 2000-09-05
AU761035B2 (en) 2003-05-29
AU4482699A (en) 2000-03-16
KR20000022858A (ko) 2000-04-25
OA11152A (en) 2003-04-17
PE20001026A1 (es) 2000-10-11
AP1118A (en) 2002-11-21
EE9900457A (et) 2000-04-17

Similar Documents

Publication Publication Date Title
PT1252170E (pt) Cristalizacao selectiva do acido 3-piridil-1-hidroxietilideno-1,1-bisfosfonico de sodio como hemipentahidrato ou monohidrato
HRP20041005B1 (hr) Kinolinski i izokinolinski derivati, postupci njihove proizvodnje, te naäśini njihove primjene kao sredstava za spreäśavanje (suzbijanje) upalnih procesa
NO20012567L (no) Azepinoindolderivater, fremstilling og anvendelse derav
BR0001486A (pt) Processos e intermediários para preparar compostos anticancerìgenos
BR0014073A (pt) Pirazolopirimidinas como agentes terapêuticos
BR9916798A (pt) 4-arilamino, 4-arilóxi e 4-ariltio diarilaminas e seus derivados como inibidores seletivos de mek
ES2009227A6 (es) Un procedimiento para la preparacion de un compuesto de oxindol farmaceuticamente activo.
PT1159279E (pt) 4-oxo-4,7-di-hidrotieno¬2,3-b|piridino-5-carboxamidas como agentes antivirais
PT1307455E (pt) Inibidores de adesao celular mediada por (alfa)l (beta)2
CY1115227T1 (el) Νεοι καταστολεις φωσφοδιεστερασης (phosphodiesterase)
ES2159488B1 (es) Procedimiento para la preparacion de derivados de pirimidona con actividad antifungica.
BR0210531A (pt) Derivados de ácido sulfÈnico
TR200402787T4 (tr) @İkameliÁ}SBÁNikotinÁtürevleriÁveÁaraÁbileşikleriÁüretmeÁmetodu
DK1240157T3 (da) Substituerede N-benzyl-indol-3-yl-glyoxylsyrederivater med antitumorvirkning
TR200103457T2 (tr) 4-Fenil-Pirimidin Türevleri.
TR199902138A2 (xx) Trovafloksasin asit tuzlar�n�n haz�rlanmas�.
PT1147119E (pt) Derivados 2,3-o-isopropilideno de monossacaridos como inibidores de adesao celular
BRPI0013751B8 (pt) processo para produção de derivados de ácido naftiridina-3-carboxílico.
TWI264435B (en) Intermediates for the production of quinoline carboxylic acid derivatives
PT1370513E (pt) Sais de adicao do acido malico de terbinafina
BRPI0017522B8 (pt) processo para preparação de secretagogos de hormônio de crescimento e polimorfo
IN2003CH01314A (en) Method for production of D-pantothenic acid and/or salts thereof as adjunct for animal feedstuffs
ECSP993123A (es) Procedimiento para preparar sales de trovafloxacina de adicion de acidos
UY25592A1 (es) Derivados de ciclohexano condensados con quinolina
BR9912839A (pt) Derivados de piperazinomas e suas aplicações